Johnson & JohnsonvsPrestige Consumer Healthcare

JNJ and PBH stock compared: price, dividend, valuation and results, from SEC filings.

PBH

Prestige Consumer Healthcare Inc.

$49.63

Value $2.4B

+0.06%
PBH's page

Johnson & Johnson (JNJ) has a market value of $652B and Prestige Consumer Healthcare (PBH) $2.4B. Over the last year, with dividends, JNJ moved +36.6% and PBH -15.1%. The P/E is 40.5 for JNJ and 15.2 for PBH. Dividend yield: JNJ 1.95%, PBH none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$652B

    PBH$2.4B

    JNJ is 277 times PBH

  • Revenue, 12 months

    JNJ$99.3B

    PBH$1.2B

    JNJ is 85 times PBH

  • Net income, 12 months

    JNJ$16.1B

    PBH$155M

    JNJ is 104 times PBH

  • Operating margin

    JNJ–

    PBH25.0%

  • ROIC

    JNJ12.4%

    PBH7.0%

    5.4 points apart

  • P/E

    JNJ40.5

    PBH15.2

    JNJ is 2.7 times PBH

  • Dividend yield

    JNJ2.0%

    PBH0.0%

    2.0 points apart

  • 5-year return

    JNJ+90.9%

    PBH-14.8%

    105.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+90.9%

PBH-14.8%

10015020020222023202420252026
Returns by period
PeriodJNJWith dividendsPBHWith dividends
1 year since November 19, 2025+36.6%Price +33.6%-15.1%Price -15.1%
3 years since November 20, 2023+94.9%+24.9% a yearPrice +80.4%-15.7%-5.5% a yearPrice -15.7%
5 years since November 19, 2021+90.9%+13.8% a yearPrice +66.0%-14.8%-3.2% a yearPrice -14.8%
10 years since November 21, 2016+206.5%+11.9% a yearPrice +135.2%+1.2%+0.1% a yearPrice +1.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonPBHPrestige Consumer Healthcare

Valuation

JNJPBH
Valuation
Price$270.47$49.63
Market value$652B$2.4B
Enterprise value (EV)$679B$4.4B
P/E40.515.2
P/E, 5-year median21.916.3
P/B8.01.2
EV/EBIT38.315.1
Free cash flow yield3.2%9.1%

Results and growth

JNJPBH
Results and growth
Revenue, 12 months$99.3B$1.2B
Net income, 12 months$16.1B$155M
Free cash flow, 12 months$20.6B$214M
Earnings per share, 12 months$6.59$3.24
Revenue growth, year on year6.1%-4.3%
Revenue growth a year, past+2.7%over 5 years+2.9%over 5 years
EPS growth a year, past+14.9%over 5 years+3.8%over 5 years

Margins and returns on capital

JNJPBH
Margins and returns on capital
Gross margin67.6%52.5%
Operating margin–25.0%
Net margin16.2%13.3%
ROIC12.4%7.0%
ROE19.7%8.3%

Balance sheet

JNJPBH
Balance sheet
Cash$17.2B$47M
Total debt$44.7B$2.1B
Net debt / EBITDA1.16.4
Interest cover18.0×–

Dividends and buybacks

JNJPBH
Dividends and buybacks
Dividend yield2.0%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%6.7%
Shareholder yield2.9%6.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or PBH

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Prestige Consumer Healthcare?

By market value, Johnson & Johnson ($652B) is about 277.2 times Prestige Consumer Healthcare ($2.4B), at today's prices.

How did JNJ and PBH stock do over the last 10 years?

Since November 21, 2016, JNJ's price moved +135.2% and PBH's +1.2%. With dividends: JNJ +206.5% (+11.9% a year), PBH +1.2% (+0.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or PBH?

The dividend yield at today's price is 1.95% for Johnson & Johnson and none for Prestige Consumer Healthcare. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and PBH?

At today's price, the P/E is 40.5 for JNJ and 15.2 for PBH. The median of the last five years was 21.9 and 16.3, which shows where each stands against its own past.

Which has the higher profit margins, Johnson & Johnson or Prestige Consumer Healthcare?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 13.3% for Prestige Consumer Healthcare, and the operating margin – and 25.0%. Revenue was $99.3B and $1.2B.

Which is the better investment, Johnson & Johnson or Prestige Consumer Healthcare?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.